Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: The C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease

Jessica Caprioli, Federica Castelletti, Sara Bucchioni, Paola Bettinaglio, Elena Bresin, Gaia Pianetti, Sara Gamba, Simona Brioschi, Erica Daina, Giuseppe Remuzzi, Marina Noris

Research output: Contribution to journalArticle

250 Citations (Scopus)

Abstract

Mutations in complement factor H (HF1) gene have been reported in non-Shiga toxin-associated and diarrhoea-negative haemolytic uraemic syndrome (D-HUS). We analysed the complete HF1 in 101 patients with HUS, in 32 with thrombotic thrombocytopenic purpura (TTP) and in 106 controls to evaluate the frequency of HF1 mutations, the clinical outcome in mutation and non-mutation carriers and the role of HF1 polymorphisms in the predisposition to HUS. We found 17 HF1 mutations (16 heterozygous, one homozygous) in 33 HUS patients. Thirteen mutations were located in exons XXII and XXIII. No TTP patient carried HF1 mutations. The disease manifested earlier and the mortality rate was higher in mutation carriers than in non-carriers. Kidney transplants invariably failed for disease recurrences in patients with HF1 mutations, while in non-mutated patients half of the grafts were functioning after 1 year. Three HF1 polymorphic variants were strongly associated with D-HUS: -257T (promoter region), 2089G (exonXIV, silent) and 2881T (963Asp, SCR16). The association was stronger in patients without HF1 mutations. Two or three disease-associated variants led to a higher risk of HUS than a single one. Analysis of available relatives of mutated patients revealed a penetrance of 50%. In 5/9 families the proband inherited the mutation from one parent and two disease-associated variants from the other, while unaffected carriers inherited the protective variants. In conclusion HF1 mutations are frequent in patients with D-HUS (24%). Common polymorphisms of HF1 may contribute to D-HUS manifestation in subjects with and without HF1 mutations.

Original languageEnglish
Pages (from-to)3385-3395
Number of pages11
JournalHuman Molecular Genetics
Volume12
Issue number24
DOIs
Publication statusPublished - Dec 15 2003

Fingerprint

Complement Factor H
Hemolytic-Uremic Syndrome
Mutation
Genes
Diarrhea
Thrombotic Thrombocytopenic Purpura
Transplants
Penetrance
Mutation Rate
Genetic Promoter Regions
Exons

ASJC Scopus subject areas

  • Genetics

Cite this

Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome : The C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. / Caprioli, Jessica; Castelletti, Federica; Bucchioni, Sara; Bettinaglio, Paola; Bresin, Elena; Pianetti, Gaia; Gamba, Sara; Brioschi, Simona; Daina, Erica; Remuzzi, Giuseppe; Noris, Marina.

In: Human Molecular Genetics, Vol. 12, No. 24, 15.12.2003, p. 3385-3395.

Research output: Contribution to journalArticle

Caprioli, Jessica ; Castelletti, Federica ; Bucchioni, Sara ; Bettinaglio, Paola ; Bresin, Elena ; Pianetti, Gaia ; Gamba, Sara ; Brioschi, Simona ; Daina, Erica ; Remuzzi, Giuseppe ; Noris, Marina. / Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome : The C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. In: Human Molecular Genetics. 2003 ; Vol. 12, No. 24. pp. 3385-3395.
@article{8b406228f5354cacb66679b7fe6c1082,
title = "Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: The C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease",
abstract = "Mutations in complement factor H (HF1) gene have been reported in non-Shiga toxin-associated and diarrhoea-negative haemolytic uraemic syndrome (D-HUS). We analysed the complete HF1 in 101 patients with HUS, in 32 with thrombotic thrombocytopenic purpura (TTP) and in 106 controls to evaluate the frequency of HF1 mutations, the clinical outcome in mutation and non-mutation carriers and the role of HF1 polymorphisms in the predisposition to HUS. We found 17 HF1 mutations (16 heterozygous, one homozygous) in 33 HUS patients. Thirteen mutations were located in exons XXII and XXIII. No TTP patient carried HF1 mutations. The disease manifested earlier and the mortality rate was higher in mutation carriers than in non-carriers. Kidney transplants invariably failed for disease recurrences in patients with HF1 mutations, while in non-mutated patients half of the grafts were functioning after 1 year. Three HF1 polymorphic variants were strongly associated with D-HUS: -257T (promoter region), 2089G (exonXIV, silent) and 2881T (963Asp, SCR16). The association was stronger in patients without HF1 mutations. Two or three disease-associated variants led to a higher risk of HUS than a single one. Analysis of available relatives of mutated patients revealed a penetrance of 50{\%}. In 5/9 families the proband inherited the mutation from one parent and two disease-associated variants from the other, while unaffected carriers inherited the protective variants. In conclusion HF1 mutations are frequent in patients with D-HUS (24{\%}). Common polymorphisms of HF1 may contribute to D-HUS manifestation in subjects with and without HF1 mutations.",
author = "Jessica Caprioli and Federica Castelletti and Sara Bucchioni and Paola Bettinaglio and Elena Bresin and Gaia Pianetti and Sara Gamba and Simona Brioschi and Erica Daina and Giuseppe Remuzzi and Marina Noris",
year = "2003",
month = "12",
day = "15",
doi = "10.1093/hmg/ddg363",
language = "English",
volume = "12",
pages = "3385--3395",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "24",

}

TY - JOUR

T1 - Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome

T2 - The C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease

AU - Caprioli, Jessica

AU - Castelletti, Federica

AU - Bucchioni, Sara

AU - Bettinaglio, Paola

AU - Bresin, Elena

AU - Pianetti, Gaia

AU - Gamba, Sara

AU - Brioschi, Simona

AU - Daina, Erica

AU - Remuzzi, Giuseppe

AU - Noris, Marina

PY - 2003/12/15

Y1 - 2003/12/15

N2 - Mutations in complement factor H (HF1) gene have been reported in non-Shiga toxin-associated and diarrhoea-negative haemolytic uraemic syndrome (D-HUS). We analysed the complete HF1 in 101 patients with HUS, in 32 with thrombotic thrombocytopenic purpura (TTP) and in 106 controls to evaluate the frequency of HF1 mutations, the clinical outcome in mutation and non-mutation carriers and the role of HF1 polymorphisms in the predisposition to HUS. We found 17 HF1 mutations (16 heterozygous, one homozygous) in 33 HUS patients. Thirteen mutations were located in exons XXII and XXIII. No TTP patient carried HF1 mutations. The disease manifested earlier and the mortality rate was higher in mutation carriers than in non-carriers. Kidney transplants invariably failed for disease recurrences in patients with HF1 mutations, while in non-mutated patients half of the grafts were functioning after 1 year. Three HF1 polymorphic variants were strongly associated with D-HUS: -257T (promoter region), 2089G (exonXIV, silent) and 2881T (963Asp, SCR16). The association was stronger in patients without HF1 mutations. Two or three disease-associated variants led to a higher risk of HUS than a single one. Analysis of available relatives of mutated patients revealed a penetrance of 50%. In 5/9 families the proband inherited the mutation from one parent and two disease-associated variants from the other, while unaffected carriers inherited the protective variants. In conclusion HF1 mutations are frequent in patients with D-HUS (24%). Common polymorphisms of HF1 may contribute to D-HUS manifestation in subjects with and without HF1 mutations.

AB - Mutations in complement factor H (HF1) gene have been reported in non-Shiga toxin-associated and diarrhoea-negative haemolytic uraemic syndrome (D-HUS). We analysed the complete HF1 in 101 patients with HUS, in 32 with thrombotic thrombocytopenic purpura (TTP) and in 106 controls to evaluate the frequency of HF1 mutations, the clinical outcome in mutation and non-mutation carriers and the role of HF1 polymorphisms in the predisposition to HUS. We found 17 HF1 mutations (16 heterozygous, one homozygous) in 33 HUS patients. Thirteen mutations were located in exons XXII and XXIII. No TTP patient carried HF1 mutations. The disease manifested earlier and the mortality rate was higher in mutation carriers than in non-carriers. Kidney transplants invariably failed for disease recurrences in patients with HF1 mutations, while in non-mutated patients half of the grafts were functioning after 1 year. Three HF1 polymorphic variants were strongly associated with D-HUS: -257T (promoter region), 2089G (exonXIV, silent) and 2881T (963Asp, SCR16). The association was stronger in patients without HF1 mutations. Two or three disease-associated variants led to a higher risk of HUS than a single one. Analysis of available relatives of mutated patients revealed a penetrance of 50%. In 5/9 families the proband inherited the mutation from one parent and two disease-associated variants from the other, while unaffected carriers inherited the protective variants. In conclusion HF1 mutations are frequent in patients with D-HUS (24%). Common polymorphisms of HF1 may contribute to D-HUS manifestation in subjects with and without HF1 mutations.

UR - http://www.scopus.com/inward/record.url?scp=0242601270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242601270&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddg363

DO - 10.1093/hmg/ddg363

M3 - Article

C2 - 14583443

AN - SCOPUS:0242601270

VL - 12

SP - 3385

EP - 3395

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 24

ER -